Lance Armstrong does not appear to have any friends at the New York Times, who published yesterday a story so strongly worded that it might be called an obituary for the cyclist's career. Armstrong is probably more popular in Philadelphia -- where his Livestrong awareness campaign is giving hope to cancer survivors and victims alike.
Armstrong appeared in the area for Livestrong Challenge Philly, which included a 5K and 10K run or walk on Saturday and bicycle rides on Sunday in 10, 20, 45, 75 and 100-mile categories. The event was based in Blue Bell on the Montgomery County Community College campus. This year, Livestrong expanded its Philadelphia agenda to a two-day event.
Livestrong invites children suffering from cancer to participate in the event via pedicab, which gives them an opportunity to take part in a vigorous physical activity. And all the participants receive a yellow rose -- a nod to Armstrong's Texas roots.
The Times suggests that doping accusations that have plagued Armstrong could undermine the significant work he has done to boost awareness of cancer and serve as a highly visible example of the triumphs that survivors can accomplish. The Times re-casts several longstanding doping accusations against Armstrong and calls him a "control freak" and an "intense micromanager of his image."
In an editorial Armstrong wrote for the Philadelphia Inquirer on Friday, he explains the impact that cancer will have on Pennsylvania.
"About 75,000 Pennsylvanians will get a cancer diagnosis this year, and 12 million Americans live with the disease and its consequences," writes Armstrong. "Relatively few have access to programs to help restart their lives after a cancer fight, even though the effects of the disease can linger long after treatment has ended."
Livestrong Challenge Philly is the first cycling event Armstrong has joined since his 23-rd place appearance in the Tour de France. Armstrong was forced to withdraw from the Leadville Trail 100 race earlier this month, citing an injury from the Tour de France that continues to bother him.
